CDX-1140 Demonstrates Clinical and Biological Activity in Patients with Advanced Solid Tumors in Phase 1 Dose Escalation Study

    NEXT STORY
    Centrexion Therapeutics Announces CNTX-4975 Data Presentations at the 2019 American College of Rheumatology Annual Meeting and the 2019 American Academy of Physical Medicine and Rehabilitation Annual Assembly
    PREV STORY
    Neon Therapeutics Announces Updated Data Presented at Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    QuestCap Appoints Mike Tyson to its Team of Global Advisors

    author_avatar
    NASDAQ Market News

    Basilea reports presentation of isavuconazole and ceftobiprole data at European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

    Post-hoc analysis on clinical response of ceftobiprole in staphylococcal bacteremia BASEL, Switzerland, April 15, ...

    author_avatar
    NASDAQ Market News

    Great Basin Announces Effectiveness of Reverse Stock Split of Common Stock and Authorized Share Increase

    SALT LAKE CITY, Dec. 28, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND), ...

    author_avatar
    NASDAQ Market News